Cargando…

Detecting primary bladder cancer using delayed (18)F-2-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography imaging after forced diuresis

OBJECTIVE: The aim of this study was to evaluate the use of delayed pelvic (18)F-2-fluoro-2-deoxy-D-glucose-positron emission tomography combined with the computed tomography (FDG-PET/CT) imaging, according to a standardized protocol including, pre-hydration and forced diuresis, for the detection of...

Descripción completa

Detalles Bibliográficos
Autores principales: Mertens, Laura S, Fioole-Bruining, Annemarie, Vegt, Erik, Vogel, Wouter V, van Rhijn, Bas WG, Horenblas, Simon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3728734/
https://www.ncbi.nlm.nih.gov/pubmed/23919066
http://dx.doi.org/10.4103/0972-3919.112718
_version_ 1782278901322481664
author Mertens, Laura S
Fioole-Bruining, Annemarie
Vegt, Erik
Vogel, Wouter V
van Rhijn, Bas WG
Horenblas, Simon
author_facet Mertens, Laura S
Fioole-Bruining, Annemarie
Vegt, Erik
Vogel, Wouter V
van Rhijn, Bas WG
Horenblas, Simon
author_sort Mertens, Laura S
collection PubMed
description OBJECTIVE: The aim of this study was to evaluate the use of delayed pelvic (18)F-2-fluoro-2-deoxy-D-glucose-positron emission tomography combined with the computed tomography (FDG-PET/CT) imaging, according to a standardized protocol including, pre-hydration and forced diuresis, for the detection of primary bladder cancer. MATERIALS AND METHODS: We evaluated 38 consecutive patients with primary cT1-4 bladder cancer. They underwent standard FDG-PET/CT followed by delayed pelvic imaging after administration of 20 mg furosemide intravenously and extra oral water intake of 0.5 L. Two observers, blinded for patient data, scored both image sets for tumor visibility using a 3-point ordinal scale: (1) negative; (2) indeterminate; (3) positive. FDG-PET/CT findings were compared with histopathology and/or follow-up imaging. RESULTS: The procedure was completed successfully in 37/38 patients and the reference standard revealed a bladder tumor in 26/37 patients. Delayed PET/CT images showed reduction of urinary bladder activity to (near) background levels in 17 of 37 cases (45.9%). Standard PET/CT detected hyper-metabolic bladder lesions in 15/37 patients (40.5%) of which 8 were indeterminate. Delayed FDG-PET/CT showed hyper-metabolic bladder lesions in 30/37 (81.1%) patients, of which 5 were indeterminate. When indeterminate lesions were considered positive, the sensitivity of standard and delayed PET/CT was 46% versus 88%, respectively. The specificity was 72% versus 36%. When indeterminate lesions were considered negative, the sensitivity of standard and delayed PET/CT was 23% and 85%. The specificity was 93% versus 73%. CONCLUSIONS: Our data suggest that delayed pelvic FDG-PET/CT imaging after forced detects more primary bladder tumors than standard FDG-PET/CT protocols. However, indeterminate bladder lesions on delayed PET/CT remain a problem and should be interpreted cautiously in order to avoid false positive results.
format Online
Article
Text
id pubmed-3728734
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-37287342013-08-05 Detecting primary bladder cancer using delayed (18)F-2-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography imaging after forced diuresis Mertens, Laura S Fioole-Bruining, Annemarie Vegt, Erik Vogel, Wouter V van Rhijn, Bas WG Horenblas, Simon Indian J Nucl Med Original Article OBJECTIVE: The aim of this study was to evaluate the use of delayed pelvic (18)F-2-fluoro-2-deoxy-D-glucose-positron emission tomography combined with the computed tomography (FDG-PET/CT) imaging, according to a standardized protocol including, pre-hydration and forced diuresis, for the detection of primary bladder cancer. MATERIALS AND METHODS: We evaluated 38 consecutive patients with primary cT1-4 bladder cancer. They underwent standard FDG-PET/CT followed by delayed pelvic imaging after administration of 20 mg furosemide intravenously and extra oral water intake of 0.5 L. Two observers, blinded for patient data, scored both image sets for tumor visibility using a 3-point ordinal scale: (1) negative; (2) indeterminate; (3) positive. FDG-PET/CT findings were compared with histopathology and/or follow-up imaging. RESULTS: The procedure was completed successfully in 37/38 patients and the reference standard revealed a bladder tumor in 26/37 patients. Delayed PET/CT images showed reduction of urinary bladder activity to (near) background levels in 17 of 37 cases (45.9%). Standard PET/CT detected hyper-metabolic bladder lesions in 15/37 patients (40.5%) of which 8 were indeterminate. Delayed FDG-PET/CT showed hyper-metabolic bladder lesions in 30/37 (81.1%) patients, of which 5 were indeterminate. When indeterminate lesions were considered positive, the sensitivity of standard and delayed PET/CT was 46% versus 88%, respectively. The specificity was 72% versus 36%. When indeterminate lesions were considered negative, the sensitivity of standard and delayed PET/CT was 23% and 85%. The specificity was 93% versus 73%. CONCLUSIONS: Our data suggest that delayed pelvic FDG-PET/CT imaging after forced detects more primary bladder tumors than standard FDG-PET/CT protocols. However, indeterminate bladder lesions on delayed PET/CT remain a problem and should be interpreted cautiously in order to avoid false positive results. Medknow Publications & Media Pvt Ltd 2012 /pmc/articles/PMC3728734/ /pubmed/23919066 http://dx.doi.org/10.4103/0972-3919.112718 Text en Copyright: © Indian Journal of Nuclear Medicine http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Mertens, Laura S
Fioole-Bruining, Annemarie
Vegt, Erik
Vogel, Wouter V
van Rhijn, Bas WG
Horenblas, Simon
Detecting primary bladder cancer using delayed (18)F-2-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography imaging after forced diuresis
title Detecting primary bladder cancer using delayed (18)F-2-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography imaging after forced diuresis
title_full Detecting primary bladder cancer using delayed (18)F-2-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography imaging after forced diuresis
title_fullStr Detecting primary bladder cancer using delayed (18)F-2-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography imaging after forced diuresis
title_full_unstemmed Detecting primary bladder cancer using delayed (18)F-2-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography imaging after forced diuresis
title_short Detecting primary bladder cancer using delayed (18)F-2-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography imaging after forced diuresis
title_sort detecting primary bladder cancer using delayed (18)f-2-fluoro-2-deoxy-d-glucose-positron emission tomography/computed tomography imaging after forced diuresis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3728734/
https://www.ncbi.nlm.nih.gov/pubmed/23919066
http://dx.doi.org/10.4103/0972-3919.112718
work_keys_str_mv AT mertenslauras detectingprimarybladdercancerusingdelayed18f2fluoro2deoxydglucosepositronemissiontomographycomputedtomographyimagingafterforceddiuresis
AT fioolebruiningannemarie detectingprimarybladdercancerusingdelayed18f2fluoro2deoxydglucosepositronemissiontomographycomputedtomographyimagingafterforceddiuresis
AT vegterik detectingprimarybladdercancerusingdelayed18f2fluoro2deoxydglucosepositronemissiontomographycomputedtomographyimagingafterforceddiuresis
AT vogelwouterv detectingprimarybladdercancerusingdelayed18f2fluoro2deoxydglucosepositronemissiontomographycomputedtomographyimagingafterforceddiuresis
AT vanrhijnbaswg detectingprimarybladdercancerusingdelayed18f2fluoro2deoxydglucosepositronemissiontomographycomputedtomographyimagingafterforceddiuresis
AT horenblassimon detectingprimarybladdercancerusingdelayed18f2fluoro2deoxydglucosepositronemissiontomographycomputedtomographyimagingafterforceddiuresis